Table of Contents
<< Previous Issue | Oct 2017 (Vol: 2017, Issue: 10) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Teva Divests Women’s Health Portfolio in a Move to Reduce Debt
- Section: Research & Development
-
Janssen Ends HCV Collaboration with Achillion Amid Crowded Market
-
Amgen Follows BMS’s Lead With a US$1.5 B Collaboration With CytomX
-
Roche Partners with Warp Drive Bio in Search of New Antibiotic Classes